Human Microbiome Market Trend- Growing Awareness About Human Microbiome Therapy

14 Jun 2022
www.biospace.com
Increasing applications of human microbiome in healthcare industry, rising incidence of chronic and rare diseases across the globe, and increasing funds for research on microbiome drugs are some key factors expected to drive global Human Microbiome market growth. According to Emergen Research, the global human microbiome market size was USD 376.3 million in 2019 and is expected to reach USD 1,689.5 million in 2027 and register a robust revenue CAGR of 21.8% during the forecast period, 2020-2027. Market Dynamics: Human microbiome is the entire collection of microbes residing on the surface, corresponding anatomical sites such as skin, oral mucosa, biliary duct, mammary gland as well as within human tissues and biofluids. Bacteria, fungi, viruses, archaea, and protozoa are some common types of human microbiota. It plays a crucial role in modern healthcare as it helps in easy digestion of food, production of various vitamins, and proper regulation of the immune system. Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ Factors such as increasing prevalence of various chronic and lifestyle associated diseases such as diabetes, cancer, gynecological diseases, neonatal disorders, obesity, genetic disorders, and bacterial infections, high focus on development of microbiome therapeutics, and increasing number of hospitals and research laboratories are expected to drive global market growth. In addition, rising geriatric population, increasing awareness about the benefits of probiotics and prebiotics, and rising funds by public and private sectors for research are expected to drive global market revenue growth going ahead. However, unawareness about probiotics and prebiotics in many developing and underdeveloped economies, lack of well-developed healthcare infrastructure, and low budget scenarios for research and development activities are some key factors that can hamper market during the forecast period. COVID-19 Impact Analysis Social distancing and restrictions severely disrupted businesses and operations Lockdowns caused disruptions in transportation and logistics Impacted manufacturing activities and mining operations globally Took a toll on economy of various countries Caused sudden and drastic downturn in economic activity Disrupted agriculture, fisheries, dairy, and other sectors Caused loss of employment and financial crisis Supply impacts were further compounded owing to reduced disposable income Emergence of variants continue to cause concerns and impact normal routines Therapeutics Segment to Account for Largest Revenue Share: The therapeutics segment is expected to account for largest revenue share owing to rising prevalence of chronic and rare diseases, availability of various therapeutic drugs, and rising focus on developing more effective microbiome drugs for diseases such as inflammatory bowel disease, and metabolic disorders, and clostridium difficile infection. Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ Infectious Diseases Segment To Register Significant Revenue CAGR: The infectious diseases segment is expected to register significant revenue growth during the forecast period owing to rising prevalence of infectious diseases across the globe, increasing need for advanced therapeutic solutions for treating infectious diseases, and rising investments in R&D activities. North America to Lead In Terms of Revenue Share: North America is expected to account for largest revenue share in the global market over the forecast period. This can be attributed to factors such as rising prevalence of various infectious and chronic diseases and lifestyle associated disorders, presence of leading market players, ongoing research on upgrading microbiome therapy, and rising investments in R&D activities. Major Companies in the Market Include: Seres Therapeutics Synlogic, Inc. Vedanta Biosciences, Inc. Evelo Biosciences, MicroBiome Therapeutics, LLC 4D Pharma PLC Osel Inc. MetaboGen AB Symbiotix Biotherapies, Inc. Second Genome Inc. Browse Full Report Description + Research Methodology + Table of Content + Infographics@ For the purpose of this report, Emergen Research has segmented the global human microbiome market on the basis of product, type, technology, application, end-use, and region: Product Outlook (Revenue, USD Million; 2017-2027) Drugs Foods Probiotics Medical Foods Prebiotics Diagnostic Tests Type Outlook (Revenue, USD Million; 2017-2027) Microbiome Drugs Fecal Microbiota Transplantation Technology Outlook (Revenue, USD Million; 2017-2027) Proteomics Genomics Metabolomics Application Outlook (Revenue, USD Million; 2017-2027) Diagnostics Therapeutics Diseases Outlook (Revenue, USD Million; 2017-2027) Inflammatory Diseases Infectious Diseases Cancer Metabolic Disorders Cardiovascular Disease Irritable Bowel Syndrome Neurological Disorders Hematological Disorders Others Regional Outlook (Revenue, USD Million; 2017–2027) North America U.S. Canada Mexico Europe Germany France U.K. BENELUX Italy Rest of Europe Asia Pacific China India Japan South Korea Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa Saudi Arabia U.A.E. South Africa Turkey Rest of MEA Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@ Read our Publication on different Websites: Emergen Research disqus Account Emergen Research vk.com Account Emergen Research padlet Account Emergen Research feedsfloor Account Emergen Research slideserve Account Emergen Research powershow Account Emergen Research 4shared Account Emergen Research authorstream Account Emergen Research animoto Account Emergen Research slideshare Account About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: Direct Line: +1 (604) 757-9756 E-mail: sales@emergenresearch.com Visit for More Insights: Explore Our Custom Intelligence services | Growth Consulting Services Press Release Available @
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.